Home Euprolactinemic galactorrhea secondary to domperidone treatment
Article
Licensed
Unlicensed Requires Authentication

Euprolactinemic galactorrhea secondary to domperidone treatment

  • Arzu Meltem Demir EMAIL logo , Zarife Kuloglu , Merih Berberoglu and Aydan Kansu
Published/Copyright: March 7, 2015

Abstract

Milk leakage from the breast, which is known as galactorrhea, can be caused by a number of pharmacological, physical, and tumoral factors. Galactorrhea is a well-known side effect of domperidone, and is usually associated with hyperprolactinemia. However, euprolactinemic galactorrhea secondary to domperidone is very rarely seen and has yet to be reported in children before. Here, we report an adolescent with euprolactinemic galactorrhea caused by domperidone.


Corresponding author: Arzu Meltem Demir, MD, Ankara University School of Medicine Pediatric Gastroenterology Department, Cebeci, Ankara, Turkey, Phone: +90 505 2520216, Fax: +90 312 3191440, E-mail:

References

1. Katznelson L, Klibanski A. Hyperprolactinemia: physiology and clinical approach. In: Krisht AF, Tindall GT, editors. Pituitary disorders: comprehensive management. Baltimore: Lippincott Williams & Wilkins, 1999;189–98.Search in Google Scholar

2. Maton PN. Profile and assessment of GERD pharmacotherapy. Cleve Clin J Med 2003;70(Suppl 5):51–70.10.3949/ccjm.70.Suppl_5.S51Search in Google Scholar

3. Campbell-Yeo ML, Allen AC, Joseph KS, Ledwidge JM, Caddell K, et al. Effect of domperidone on the composition of preterm human breast milk. Pediatrics 2010;125:107–14.10.1542/peds.2008-3441Search in Google Scholar

4. De S, Taylor CM. Domperidone toxicity in an infant on maintenance haemodialysis. Pediatr Nephrol 2007;22;161–2.10.1007/s00467-006-0263-7Search in Google Scholar

5. Cann PA, Read NW, Holdsworth CD. Galactorrhoea as side effect of domperidone. Br Med J (Clin Res Ed) 1983;286:1395–6.10.1136/bmj.286.6375.1395Search in Google Scholar

6. Izquierdo Prieto OM, Moreno Alía E, Rosillo González A. Galactorrhea induced by lansoprazole. Aten Primaria 2004;34:325–6.10.1016/S0212-6567(04)79506-2Search in Google Scholar

7. Pratheesh PJ, Praharaj SK, Srivastava A. Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination. Psychopharmacol Bull 2011;44:70–3.Search in Google Scholar

8. Mahasuar R, Majhi P, Ravan JR. Euprolactinemic galactorrhea associated with use of imipramine and escitalopram in a postmenopausal woman. Gen Hosp Psychiatry 2010;32:341.10.1016/j.genhosppsych.2009.07.006Search in Google Scholar PubMed

9. Kwak WJ, Patel A, Haq F, Siddiqui F, Younis M, et al. Antipsychotic-induced euprolactinemic galactorrhea in an adolescent girl: a case report. Prim Care Companion CNS Disord 2012;14.10.4088/PCC.11l01239Search in Google Scholar PubMed PubMed Central

10. Ataya KM, Subramanian MG, Lawson DM, Gala RR. Euprolactinemic galactorrhea. Response of bioassayable prolactin to thyrotropin-releasing hormone. J Reprod Med 1996;41:156–60.Search in Google Scholar

Received: 2014-3-17
Accepted: 2015-2-4
Published Online: 2015-3-7
Published in Print: 2015-7-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Thyroid
  3. Thyroid disorders revisited
  4. Genetic analysis of the paired box transcription factor (PAX8) gene in a cohort of Polish patients with primary congenital hypothyroidism and dysgenetic thyroid glands
  5. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases
  6. Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients
  7. Evaluation of inflammatory and oxidative biomarkers in children with well-controlled congenital hypothyroidism
  8. Investigation of autoimmune diseases accompanying Hashimoto’s thyroiditis in children and adolescents and evaluation of cardiac signs
  9. Neonatal thyroid storm accompanied with severe anaemia
  10. Functional characterization of the novel sequence variant p.S304R in the hinge region of TSHR in a congenital hypothyroidism patients and analogy with other formerly known mutations of this gene portion
  11. Subclinical hypothyroidism as a rare cofactor in chronic kidney disease (CKD) – related anemia
  12. Cytometric analysis of perforin expression in NK cells, CD8+, and CD4+ lymphocytes in children with autoimmune Hashimoto’s thyroiditis – a preliminary study
  13. Papillary thyroid cancer and autoimmune polyglandular syndrome
  14. Review article
  15. Should radioiodine be the first-line treatment for paediatric Graves’ disease?
  16. Image in pediatric endrocrinology
  17. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease
  18. Original articles
  19. Novel mutations of DAX1 (NR0B1) in two Chinese families with X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism
  20. Rickets and vitamin D deficiency in Alaska native children
  21. Persistent elevation of fibroblast growth factor 23 concentrations in healthy appropriate-for-gestational-age preterm infants
  22. Parents’ experiences of having a baby with ambiguous genitalia
  23. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty
  24. Congenital adrenal hyperplasia in children – a survey on the current practice in the UK
  25. Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome
  26. Influence of the body weight on the onset and progression of puberty in boys
  27. Therapy monitoring in congenital adrenal hyperplasia by dried blood samples
  28. Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene
  29. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds
  30. Monitoring gonadotropin-releasing hormone analogue (GnRHa) treatment in girls with central precocious puberty: a comparison of four methods
  31. Dietary intake, body composition, and physical activity among young patients with type 1 diabetes mellitus
  32. Metabolic syndrome in obese children and adolescents in Serbia: prevalence and risk factors
  33. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy
  34. Patient reports
  35. 17α-Hydroylase/17,20-lyase deficiency related to P.Y27*(c.81C>A) mutation in CYP17A1 gene
  36. A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature
  37. Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene
  38. Triple A syndrome with a novel indel mutation in the AAAS gene and delayed puberty
  39. Case report: long-term follow-up of a 45,X male with SHOX haploinsufficiency
  40. Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review
  41. Successful use of continuous subcutaneous hydrocortisone infusion after bilateral adrenalectomy secondary to bilateral pheochromocytoma
  42. Donohue syndrome: a new case with a new complication
  43. Euprolactinemic galactorrhea secondary to domperidone treatment
  44. 17βHSD-3 enzyme deficiency due to novel mutations in the HSD17B3 gene diagnosed in a neonate
  45. Two different patterns of mini-puberty in two 46,XY newborns with 17β-hydroxysteroid dehydrogenase type 3 deficiency
  46. Short communication
  47. Early onset hearing loss in autosomal recessive hypophosphatemic rickets caused by loss of function mutation in ENPP1
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0118/html
Scroll to top button